Ampligen to be studied in phase IIa human challenge trial as intranasal antiviral therapy July 12, 2021
Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer July 12, 2021
ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults July 12, 2021
RSS